In this section
Data is submitted annually to the NHS Newborn Blood Spot Screening Programme regarding performance of the regional newborn blood spot programme in relation to key process and clinical referral standards.
Performance data is also collated quarterly and reports are presented to the Greater Manchester and Lancashire and South Cumbria Quality and Commissioning Groups.
Newborn Screening Laboratory annual reports
Monthly avoidable repeat reports
- November 2021
- December 2021
- January 2022
- February 2022
- March 2022
- April 2022
- May 2022
- June 2022
- July 2022
- August 2022
- September 2022
- October 2022
- November 2022
- December 2022
- January 2023
- February 2023
- March 2023
- April 2023
Quarterly reports
- Quarter 3 2020/21
- Quarter 4 2020/21
- Quarter 1 2021/22
- Quarter 2 2021/22
- Quarter 3 2021/22
- Quarter 4 2021/22
- Quarter 1 2022/23
- Quarter 2 2022/23
- Quarter 3 2022/23
- Quarter 4 2022/23
Other reports/audits
- Newborn Screening Carrier Audit, July 2022
- Audit of the linkage of antenatal and newborn screening results in the Sickle Cell and Thalassaemia Screening Programme in Greater Manchester, Lancashire and South Cumbria, May 2018
- Carriers of abnormal haemoglobins – result communication audit by Helen Jopling, November 2014
- Sickle Screening Turnaround Time Re-audit by Suzanne Armitage, May 2014
- Blood spot sample quality project by Laura Hamilton, April 2013
- Postal audit by Helen Jopling, December 2012
(Last reviewed May 2023)